UBS Group
ROIVW

UBS Group’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

UBS Group’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,145
Closed -$2.22K – 11053
2022
Q4 		$2.22K Sell
1,145
-6,023
-84% -$6.59K ﹤0.01% 9712
2022
Q3 		$3K Sell
7,168
-205
-3% -$109 ﹤0.01% 9642
2022
Q2 		$4K Sell
7,373
-75
-1% -$39 ﹤0.01% 9201
2022
Q1 		$7K Sell
7,448
-5,918
-44% -$7.52K ﹤0.01% 8890
2021
Q4 		$27K Buy
+13,366
New +$20.4K ﹤0.01% 7519

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

UBS Group's ROIVW Position: Q1 2023 in Review

UBS Group sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q1 2023, closing a stake of 1,145 shares — an estimated $2.22K sold.

UBS Group first reported a position in ROIVW in Q4 2021 and held it in 5 quarters. The position peaked at $27K in Q4 2021. 23 funds tracked by Wall St. Rank hold ROIVW as of Q1 2023.

  • UBS Group reported no remaining Roivant Sciences Ltd. Warrant position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 1,145 Roivant Sciences Ltd. Warrant shares in Q1 2023, an estimated $2.22K.
  • UBS Group first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 5 quarters.
  • UBS Group's Roivant Sciences Ltd. Warrant position peaked at $27K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.